SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is surging following a blowout second-quarter earnings report, characterized by massive revenue growth and significantly raised full-year guidance that has silenced many skeptics. Community sentiment is overwhelmingly bullish, with investors aggressively debating the stock's potential to sustain this momentum toward new highs and celebrating the company's strong positioning within the expanding AI software infrastructure.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is drawing significant attention as investors speculate on a turnaround driven by improving advertising demand, a surge in subscription growth, and anticipation ahead of its upcoming earnings report. The community is sharply divided, with some betting on a potential short squeeze and long-term upside for its AI-driven initiatives, while vocal critics remain skeptical of management's leadership and the commercial viability of its hardware projects.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to an unexpected $1.4 billion convertible debt exchange for equity, which has sparked intense debate over the balance between long-term financial health and short-term share dilution. The community remains deeply divided, with some investors viewing the move as a strategic cleanup of the balance sheet ahead of potential acquisition activity, while others are frustrated by the downward price pressure and the ongoing lack of clarity regarding management's broader acquisition strategy.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant investor buzz following an expanded global footprint with new drug approvals in the UAE, while the community remains hyper-focused on upcoming earnings and potential partnership news. Investors are actively debating whether these developments and the companys recent activity indicate a turning point for the stock amidst heavy short interest.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies is trending as investors react to a significant earnings beat, raised revenue guidance, and the acquisition of Astrobotic Technology, which secures the firm a pivotal role in government lunar initiatives. While some community members express frustration over recent price volatility and disconnects from broader space sector momentum, others are actively accumulating shares, citing a massive backlog and critical partnerships that position the company as a key infrastructure player in the evolving space economy.

Backblaze, Inc. operates as a cloud provider for businesses and consumers to store, use, and protect their data. The firm provides a foundation for businesses, developers, IT professionals, and individuals to store, backup, and archive data, host content, manage media, and build their applications. It also offers B2 Cloud Storage and Computer Backup services. The company was founded by Timothy Nufire, Gleb Budman, Charles Jones, Kwok Hang Ng, Brian Wilson, Nilay Patel and Damon Uyeda in 2007 and is headquartered in San Francisco, CA.

Backblaze Inc - Ordinary Shares - Class A

Backblaze is surging following the announcement of a five-year, $335 million strategic agreement with CoreWeave to provide cloud storage infrastructure for AI workloads. The community is actively debating the stock's valuation and long-term potential, with bulls pointing to the contract as a major validator of the company's role in the AI stack while bears raise concerns about potential future share offerings.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing heightened market activity following a favorable 10-3 advisory committee vote regarding the efficacy of its lead candidate, RP1, for advanced melanoma. Community sentiment is deeply divided, with many debating whether this positive vote will lead to regulatory approval or if the company will still face a third complete response letter, given the FDA's historically critical stance on the trial's data quality.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is trending as investors and analysts closely monitor the stock ahead of its upcoming earnings report, with sentiment divided between enthusiasm for the company's long-term pivot toward high-margin monetization and concerns over short-term growth deceleration. The community is actively debating the stock's valuation, recent analyst price target adjustments, and whether the company's aggressive investments in AI and subscription tiering will drive a breakout or lead to further volatility.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is seeing heightened activity as the community anticipates the upcoming 80th event data from the Phase 3 REGAL trial, with investors actively debating potential buyout rumors and clinical milestones. The stock is drawing intense focus from both long-term bulls and short-sellers who are closely tracking institutional ownership shifts and market structure signals, such as limited option expirations, while waiting for a major catalyst.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently trending as investors focus on recent pipeline updates and the long-term commercial potential of Casgevy, while the community remains divided over management's performance and the stock's stagnant price action. Market sentiment is heavily influenced by expectations for upcoming clinical trial readouts and ongoing speculation regarding potential M&A activity within the gene-editing sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nuveen Preferred Securities & Income Opportunities Fund operates as a closed-end investment fund. It seeks to provide high level current income and total return. The company was founded in 2003 and is headquartered in Chicago, IL.

Nuveen Preferred & Income Term Fund

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$20.68
Prev Close	$20.72
Open	$20.64
Dividend Yield	9.37%
50-Day Moving Average	$20.30
Beta	0.16
Avg. Volume	0.00
PE Ratio	7.50

52-Week High	$20.55
52-Week Low	$18.71
Market Capitalization	$459.32M
EPS (Annual)	$1.97
Price to Book	1.01
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info